News

Pharma industry must transition towards innovative products: PHARMEXCIL

India's pharmaceutical industry must shift towards innovation in complex generics, including peptides, biosimilars, and biologics, to maintain its global leadership. Industry leaders emphasized the need for R&D-driven innovation beyond post-patent launches and highlighted the importance of updating pharmacy curricula to reflect current industry demands and prepare a skilled workforce for future breakthroughs.